The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Sal'kov V.N.

Nauchnyĭ tsentr nevrologii RAMN, Moskva;
Nauchnyĭ tsentr zdorov'ia deteĭ RAMN, Moskva;
Ivanovskiĭ nauchno-issledovatel'skiĭ institut materinstva i detstva im. V.I. Gorodkova

Khudoerkov R.M.

FGBU "Nauchnyĭ tsentr nevrologii" RAMN, Moskva

Voronkov D.N.

FGBU "Nauchnyĭ tsentr nevrologii" RAMN, Moskva

Sobolev V.B.

FGBU "Nauchnyĭ tsentr nevrologii" RAMN, Moskva

Kutukova K.A.

Research Center of Neurology, Moscow, Russia

Morphochemical changes in the substantia nigra cellular structures in Parkinson’s disease

Authors:

Sal'kov V.N., Khudoerkov R.M., Voronkov D.N., Sobolev V.B., Kutukova K.A.

More about the authors

Read: 2214 times


To cite this article:

Sal'kov VN, Khudoerkov RM, Voronkov DN, Sobolev VB, Kutukova KA. Morphochemical changes in the substantia nigra cellular structures in Parkinson’s disease. Russian Journal of Archive of Pathology. 2017;79(5):3‑9. (In Russ.)
https://doi.org/10.17116/patol20177953-9

Recommended articles:
Neurochemical mechanisms of tremor in Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):64-72
Cognitive impairment in patients with Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):81-90
Bladder dysfunction in patients with stages I—III of Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):91-99
A portrait of a doctor with Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):160-164
Pathomorphosis of the Parkinson’s disease against the background of DBS STN. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(2):21-27
Neuroinflammatory and neurodegenerative aspe­cts of Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3):102-111
Schi­zophrenic spectrum diso­rders and Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3):136-141

References:

  1. The demographic yearbook of Russia. 2015: Statistical handbook. Moscow: Rosstat; 2015. (In Russ.).
  2. Saner H. Substantial increase of life expectancy in Europeans: how can we explain the success? Profilakticheskaya meditsina. 2015;18(4):4-11. (In Russ.). https://doi.org/10.17116/profmed20151844-11
  3. Illarioshkin SN, Slominskii PA, Shadrina MI, Bagyeva GKh, Zagorovskaya TB, Markova ED, Karabanov AV, Poleshchuk VV, Polevaya EB, Fedorova NV, Limborskaya SA, Ivanova-Smolenskaya IA. Heterogeneity of sporadic Parkinson’s disease: molecular approach to solving the problem. Annaly klinicheskoi i eksperimental’noi nevrologii. 2007;1(1):23-31. Accessed March 30, 2017. https://www.annaly-nevrologii.ru/
  4. Bellinger FP, Bellinger MT, Seale LA, Takemoto AS, Raman AV, Takanori M, Manning-Boğ AB, Berry MJ, White LR, Ross GW. Glutathione peroxidase 4 is associated with neuromelanin in substantia nigra and dystrophic axons in putamen of Parkinson’s brain. Mol Neurodegener. 2011;6(1):8. https://doi.org/10.1186/1750-1326-6-8
  5. Fritsch T, Smyth KA, Wallendal MS, Hyde T, Leo G, Geldmacher DS. Parkinson disease: research update and clinical management. South Med J. 2012;105(12):650-656. https://doi.org/0.1097/smj.0b013e318273a60d
  6. Petrosyan TR, Gevorkyan OV, Chavushyan VA, Meliksetyan IB, Hovsepyan AS, Manvelyan LR. Effects of bacterial melanin on motor recovery and regeneration after unilateral destruction of Substantia Nigra pars compacta in rats. Neuropeptides. 2014;48(1):37-46. https://doi.org/10.1016/j. npep.2013.10.001
  7. Glass CK, Saijo K, Winner B, Marchetto MC, Gage FH. Mechanisms underlying inflammation in neurodegeneration. Cell. 2010;140(6):918-934. https://doi.org/10.1016/j.cell.2010.02.016
  8. Pannese E. Morphological changes in nerve cells during normal aging. Brain Struct Funct. 2011;216(2):85-89. https://doi.org/10.1007/s00429-011-0308-y
  9. Kordower JH, Olanow CW, Dodiya HB, Chu Y, Beach TG, Adler CH, Halliday GM. Disease duration and the integrity of the nigrostriatal system in Parkinson’s disease. Brain. 2013;136(8): 2419-2431. https://doi.org/10.1093/brain/awt192
  10. Jyothi HJ, Vidyadhara DJ, Mahadevan A, Philip M, Parmar SK, Manohari SG, Shankar SK, Raju TR, Alladi PA. Aging causes morphological alterations in astrocytes and microglia in human substantia nigra pars compacta. Neurobiol Aging. 2015;36(12):3321-3333. https://doi.org/10.1016/j.neurobiolaging.2015.08.024
  11. Dickson DW. Parkinson’s disease and parkinsonism: neuropathology. Cold Spring Harb Perspect Med. 2012;2(8):a009258 https://doi.org/0.1101/cshperspect.a009258
  12. Tong J, Ang LC, Williams B, Furukawa Y, Fitzmaurice P, Guttman M, Boileau I, Hornykiewicz O, Kish SJ. Low levels of astroglial markers in Parkinson’s disease: relationship to α-synuclein accumulation. Neurobiol Dis. 2015;82:243-253. https://doi.org/10.1016/j.nbd.2015.06.010
  13. Zecca L, Youdim M, Riederer P, Connor JR, Crichton RR. Iron, brain ageing and neurodegenerative disorders. Nat Rev. 2004;5:863-873. https://doi.org/10.1038/nrn1537
  14. Wakabayashi K, Mori F, Takahashi H. Progression patterns of neuronal loss and Lewy body pathology in the substantia nigra in Parkinson’s disease. Parkinsonism Relat Disord. 2006;12:92-98. https://doi.org/10.1016/j.parkreldis.2006.05.028
  15. Braak H, Del Tredici K, Rüb U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging. 2003;24(2):197-211. https://doi.org/10.1016/S0197-4580(02)00065-9
  16. Morris GP, Clark IA, Zinn R, Vissel B. Microglia: a new frontier for synaptic plasticity, learning and memory, and neurodegenerative disease research. Neurobiol Learn Mem. 2013;105:40-53. https://doi.org/10.1016/j.nlm.2013.07.002
  17. Illarioshkin SN, Vlasenko АG, Fedotova ЕYu. Current means for identifying the latent stage of a neurodegenerative process Annaly klinicheskoi i eksperimental’noi nevrologii. 2013;7(2):39-50. Accessed March 30, 2017. http://www.annaly-nevrologii.ru/

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.